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Short Communication
Hypolipidaemic and anti-atherosclerotic effects of lupin proteins
in a rabbit model
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The biological activities of a protein isolate from lupin (Lupinus albus) were studied in a rabbit model of atherosclerosis. Focal plaque develop-
ment was induced at both common carotid arteries by perivascular injury. After surgery, animals were fed three different diets for 90 d, all with 1 %
cholesterol, 15 % SFA and 20 % protein; the protein source was casein (CAS), lupin proteins (LUP) or 50 % CAS þ 50 % LUP (CAS þ LUP).
Lower cholesterolaemia was detected in the LUP v. the CAS group at 60 and 90 d of treatment (240·3 and 233·5 %, respectively; P,0·05).
Cryosection analyses of the carotids indicated a significant reduction in focal lesion progression in the LUP v. the CAS group (237·4 %;
P,0·05). In summary, in a rabbit model of atherosclerosis, a protein isolate from L. albus reduced cholesterolaemia and exerted a remarkable
protective activity against atherosclerosis progression.
Lupinus albus: Protein isolates: Cholesterol: Atherosclerosis: Rabbits
The growing use of legume proteins in human nutrition for
their nutraceutical properties(1 – 4) has recently suggested
detailed investigations on the possible clinical use of lupin
proteins. Lupin beans are characterised by a lower content of
antinutrients v. other legumes(5) and by an almost total absence
of phyto-oestrogens(6,7). This last feature, on the one hand,
may avoid potential problems that have been recently indi-
cated for these hormone-like components(8); on the other, it
allows a direct evaluation of the activity of ‘proteins’, inde-
pendent of other components. Lupin protein isolates are nutri-
tionally satisfactory(9,10) and have a neutral flavour(11), thus
allowing the production of food items with optimal sensory
characteristics(12).
A previous study from our group(7) investigated the potential
hypolipidaemic effect of a total protein extract from Lupinus
albus. When given to rats fed a classical cholesterol–cholic
acid regimen, lupin proteins significantly reduced both plasma
cholesterol and TAG levels v. control animals. The cholesterol
reduction appeared to be associated with a mechanism shared
with soya proteins, i.e. a direct up regulatory activity on LDL
receptors(13 – 15).
Based on recent data by our group(16) and others(17,18)
suggesting an anti-atherosclerotic effect of soya proteins,
also characterised by a cholesterol-lowering activity(1,13,15),
the impact on atherosclerosis progression of a diet contai-
ning L. albus proteins was tested in a rabbit model of
focal lipid-rich soft plaques, generated at the common
carotid arteries(19).
Materials and methods
Lupin protein preparation
A total protein isolate from L. albus seeds was manufactured
by the Fraunhofer Gesellschaft, Fraunhofer-Institute (Freising,
Germany), by an extraction and precipitation process followed
by spray drying(11). The protein percentage was 91·21 % DM.
A detailed description of the composition and a proteomic
investigation of this protein isolate have been previously
reported(11,20).
Animals, diets and experimental protocols
Procedures involving animals and their care were conducted in
compliance with national and European Union laws and
policies.
*Corresponding author: Dr Giulia Chiesa, fax þ39 02 50318284, email giulia.chiesa@unimi.it
†M. M. and C. P. Contributed equally to the study.
Abbreviations: CAS, casein; LUP, lupin protein.
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Arterial plaque formation at the common carotid artery was
induced in male New Zealand White rabbits by perivascular
injury, as described previously(19,21). Rabbits were divided into
three groups of six rabbits, balanced for body weight. After sur-
gery, rabbits were fed a 1 % cholesterol and 15 % SFA diet for
90 d, the protein source (20 % in each diet) being either casein
(CAS), 50 % CAS þ 50 % total protein isolate from L. albus
(CAS þ LUP) or total protein isolate from L. albus (LUP).
Fasting blood samples were taken before and after 30, 60
and 90 d of dietary treatments for plasma total cholesterol,
TAG and HDL-cholesterol measurements, by a Roche Diag-
nostics Cobas autoanalyser (Nutley, NJ, USA). After 90 d
diet, animals were anaesthetised with xylazine/ketamine and
then killed. Injured arteries were excised, embedded in opti-
mal cutting temperature compound for cryosections under
liquid N2 and stored at 2808C, until analyses. Plaque
volume was evaluated by measuring cross-sectional areas of
the intima every 0·25 mm within the area of plaque accumu-
lation using an image analysis system (ImageJ 1.37v; National
Institutes of Health, Bethesda, MD, USA) interfaced to a Zeiss
Axioscope microscope (Carl Zeiss, Oberkochen, Germany).
Selected sections were incubated as described(19) with mouse
monoclonal antibodies directed against rabbit smooth muscle
a-actin (HHF35; DAKO Corp., Glostrup, Denmark) and
rabbit macrophages (RAM-11; DAKO Corp.). Sections were
also stained with Oil red O to identify lipid accumulation
within the plaque(19,21). Quantification of the percentage of
plaque area covered by lipids or macrophages (i.e. with posi-
tive staining for Oil red O or for the anti-RAM-11 antibody,
respectively) was performed by using a Nikon Coolpix 950
digital camera interfaced with a Zeiss Axioscope microscope
(Carl Zeiss), followed by computer-assisted planimetry.
Statistical analyses
Data are expressed as mean values and standard deviations.
Group differences were tested for statistical significance by
multivariate ANOVA (repeated measures), followed by the
Tukey post hoc test; a value of P,0·05 was considered sta-
tistically significant. The statistical analysis was performed
using SYSTAT software (version 5.2; Systat Software, Inc.,
San Jose, CA, USA).
Results
Effect on plasma lipids of a total protein isolate from Lupinus
albus in rabbits
The presence in each diet of 1 % cholesterol and 15 % coconut
fat determined a marked increase in total cholesterol levels
in all groups (Table 1). However, whereas in CAS and
CAS þ LUP animals total cholesterol concentrations
increased progressively up to 60 d, reaching values close to
19 000 mg/l that were maintained until killing (90 d), in
LUP-fed rabbits cholesterolaemia did not undergo marked
variations after 30 d of treatment and reached a maximum of
12 500 mg/l at 90 d. As a consequence of the different
responses to the dietary treatments, a significantly lower
mean plasma cholesterolaemia was observed in LUP com-
pared with CAS animals after both 60 and 90 d of experimen-
tal diet (Table 1). No significant variations were observed for
HDL-cholesterol levels (Table 1).
A marked increase in TAG levels was observed after each
dietary treatment, with no significant differences among
groups (Table 1). However, whereas in the CAS group a
progressive rise of TAG levels was observed, in LUP-fed
rabbits triacylglycerolaemia significantly increased only after
90 d dietary treatment.
Effect on atherosclerosis development
The diet based on lupin proteins significantly affected athero-
sclerosis development (Fig. 1); at the end of the dietary treat-
ments, plaque volume was significantly reduced in LUP
Table 1. Lipid levels in rabbits fed diets containing 20 % casein (CAS), 10 % CAS þ 10 % isolate from Lupinus albus
(CAS þ LUP) or 20 % isolate from L. albus (LUP) as the protein source
(Mean values and standard deviations for six rabbits per group)*
CAS CAS þ LUP LUP
Mean SD Mean SD Mean SD
Total cholesterol (mg/l)
0 d 532·7a 91·3 530·9a 91·6 481·3a 77·6
30 d 9423·2b 3176·9 12 022·9b 2432·4 11 644·5b 2650·3
60 d 19 791·4c 5731·5 18 873·3c 3653·8 11 816·2b† 621·0
90 d 18 807·5c 2592·1 17 818·1b,c 4146·6 12 507·6b‡ 732·8
HDL-cholesterol (mg/l)
0 d 132·2a 24·3 135·1a 47·0 144·4a 12·7
30 d 490·7a 468·2 448·2a 309·5 619·4a 479·7
60 d 743·4a 407·8 622·5a 229·0 751·3a 465·8
90 d 598·6a 234·6 569·2a 426·8 599·2a 268·2
TAG (mg/l)
0 d 750·0a 192·0 850·0a 385·6 675·0a 188·8
30 d 1945·0a,b 1121·3 3950·0a 5758·4 1370·0a 745·8
60 d 8547·5b,c 4731·4 6830·0a 5648·8 3682·5a,b 2470·3
90 d 12 055·0c 5340·2 7762·5a 1533·8 10 147·5b 6063·4
a,b,c Mean values within a column with unlike superscript letters were significantly different (P,0·05; ANOVA).
* For details of diets and procedures, see Materials and methods.
† Mean value was significantly different from that of the CAS-fed animals at 60 d (P,0·05).
‡ Mean value was significantly different from that of the CAS-fed animals at 90 d (P,0·05).
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compared with CAS rabbits (P,0·05) (Fig. 1 (a)). Rabbits fed
CAS þ LUP displayed an intermediate plaque size between
CAS and LUP animals, but statistical significance v. either
comparator was not reached.
As previously described in this animal model fed the same
diet(16), CAS rabbits developed plaques characterised by a
neointimal formation devoid of smooth muscle cells and
mostly constituted by macrophages and extracellular lipids.
Compared with CAS animals, atherosclerotic plaques of
LUP rabbits displayed a reduced macrophage (223·4 %) and
lipid accumulation (236·2 %), this latter reaching statistical
significance (P,0·05) (Fig. 1 (b)).
Discussion
In the present study, lupin proteins inhibited the cholesterol
rise induced by a lipid-rich diet, confirming results previously
obtained in rats(7). No significant differences were instead
observed for triacylglycerolaemia among groups. It should
be noted, however, that, differently from the CAS group, the
increase of TAG levels in the LUP-fed rabbits occurred only
at the end of the dietary treatment (90 d). It may be speculated
that the long duration of the high-fat, high-cholesterol dietary
challenge required for the development of atherosclerotic
plaques may have overcome a possible hypotriacylglycerolae-
mic effect of lupin proteins in this model. Similarly, the
aggressive dietary treatment required to induce atherosclerotic
plaque formation may have hidden a possible hypolipidaemic
effect played by lupin proteins in the CAS þ LUP group. The
main objective of the present study was, however, the investi-
gation of the impact of lupin proteins on atherosclerosis
progression. To investigate this issue, an appropriate animal
model was selected, i.e. the rabbit that, differently from the
rat, is highly susceptible to atherosclerosis development. In
this animal model, perivascular manipulation at the common
carotid arteries, followed by a hyperlipidaemic diet, induces
the formation of focal plaques, mostly constituted by extra-
cellular lipids and macrophages(19), thus reflecting the main
features of the human arterial plaques, defined as unstable,
frequently associated with acute ischaemic events(22). This
same rabbit model has proven to be sensitive to local interven-
tions with recombinant apolipoproteins(21), as well as to
dietary treatments(16).
The diet exclusively based on L. albus proteins clearly
reduced atherosclerosis progression, possibly as a conse-
quence of the observed hypocholesterolaemic activity. The
reduction of circulating atherogenic lipoproteins by lupin pro-
teins could easily explain the lower lipid accumulation within
carotid plaques of the LUP compared with the CAS group. In
the CAS þ LUP group, where no hypocholesterolaemic effect
was observed, plaque volume was not statistically different
from that observed in the CAS rabbits. However, the
CAS þ LUP group displayed a trend toward a lower extent
of atheromas compared with the CAS group, suggesting that
the anti-atherogenic activity exerted by lupin proteins may
be partially explained by other mechanisms, in addition to
the observed reduction of cholesterolaemia. This issue will
be the object of future investigations.
While there is evidence for a vascular protective effect of
soya proteins(16 – 18), no data are available on lupin proteins,
except for those related to the hypolipidaemic activity(7,23).
Differently from soya, a relevant characteristic of lupin is
the total absence of isoflavones(6,7), which permits us to con-
clude that the observed vascular protective properties should
certainly be ascribed to the protein component.
When the nutraceutical properties of a food are due to the
proteins, it becomes very important to assess their quality
and integrity. A proteomic analysis of the protein isolate
from L. albus used in the present study was recently
reported(20). The results show that the protein isolate had
undergone limited damage, demonstrating that the manufac-
turing process had been very mild, different from the case
of commercial soya protein isolates(24).
Interestingly, in a recent study, L. albus proteins were given
as a beverage to subjects with moderate hypercholesterolae-
mia in an amount corresponding to a daily intake of approxi-
mately 35 g(25). This dietary supplementation significantly
reduced both cholesterolaemia and blood pressure, suggesting
that the beneficial effects of lupin proteins observed in animal
studies(7,26), including the present study, may occur also in
humans. While these preliminary clinical data will require
confirmation in appropriate controlled investigations, the
results of the present study suggest the potential positive
impact of lupin proteins on atherosclerosis prevention and
treatment.
Fig. 1. Histological analysis of rabbit carotid plaques. (a) Carotid plaque
volume evaluated in rabbits after perivascular injury followed by 90 d of high-
fat, high-cholesterol diet containing 20 % casein (CAS), 10 % CAS þ 10 %
isolate from Lupinus albus (CAS þ LUP) or 20 % isolate from L. albus (LUP)
as the protein source. Data are mean values (six rabbits per group), with
standard deviations represented by vertical bars. * Mean value was signifi-
cantly different from that of the CAS-fed group (P,0·05). (b) Oil red O stain-
ing of carotid sections from rabbits fed high-fat, high-cholesterol diets
containing 20 % casein (CAS) or 20 % isolate from L. albus (LUP) as protein
source (magnification £ 50). $ , Plaque formation.
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